A clinical trial shows a pill almost doubled survival for pancreatic cancer patients. Now what?
Good news is rare when it comes to pancreatic cancer. Early detection is difficult. Post-diagnosis survival times are relatively short. Existing treatments are mostly available in the disease’s early stages. Even though just 3.2% of newly diagnosed …